About
Technology
Issues
FAQ
Links
Official Page
TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.